About Us Team Pipeline News Contact Us Home

Management Team Board of Directors Key Consultants

Kinex raises more than $3 million in equity financing

Kinex Co-Founder Appointed to NYBA Board

Kinex Awarded US Patent

Start of Clinical Trial for KX2-391

KX2-391 Enters Phase 1 Clinical Trials for Oncology

More headlines ...

Board of Directors

Allen Barnett, Ph.D.

Chief Executive Officer

Johnson Y.N. Lau, M.D.

Executive Chairman

Donald Hess

Jinn Wu, Ph.D.

©2007 Kinex Pharmaceuticals. All rights reserved.